Red eye: Difference between revisions
Jump to navigation
Jump to search
Ochuko Ajari (talk | contribs) |
Ochuko Ajari (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Red eye}} | {{Red eye}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{Ochuko}} | ||
{{SK}} Bloodshot eye | {{SK}} Bloodshot eye | ||
'''For patient information, click [[Red eye (patient information)|here]]''' | |||
==[[Red eye overview|Overview]]== | |||
==[[Red eye historical perspective|Historical Perspective]]== | |||
==[[Red eye classification|Classification]]== | |||
==[[Red eye pathophysiology|Pathophysiology]]== | |||
==[[Red eye causes|Causes]]== | |||
==[[Red eye differential diagnosis|Differentiating Red eye from other Diseases]]== | |||
==[[Red eye epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Red eye natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | |||
==Diagnosis== | |||
[[Red eye history and symptoms|History and Symptoms ]] | [[ Red eye physical examination|Physical Examination]] | |||
==Treatment== | |||
[[Red eye medical therapy|Medical Therapy]] | [[Red eye primary prevention|Primary Prevention]] | [[Red eye secondary prevention|Secondary Prevention]] | [[Red eye cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Red eye future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
[[Red eye case study one|Case #1]] | |||
==Related Chapters== | ==Related Chapters== | ||
Revision as of 15:52, 22 February 2013
|
Red eye Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]
Synonyms and keywords: Bloodshot eye
For patient information, click here
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Red eye from other Diseases
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies